MedTrace Logo

Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy

NCT04767607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-03-06

No results posted yet for this study

Summary

The purpose of this study is to predict the ovarian reserve, especially premature ovarian insufficient (POI), in young breast cancer patients during chemotherapy treatment using ultrasensitive anti-Müllerian hormone (AMH) detection method.

Conditions

Sponsors & Collaborators

  • School of Biomedical Engineering, Shanghai Jiao Tong University

    collaborator UNKNOWN

  • International Peace Maternity and Child Health Hospital

    lead OTHER

Principal Investigators

  • Dongmei Lai, M.D. · The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2022-07-01
Completion
2023-07-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04767607 on ClinicalTrials.gov